INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
17/03/2024
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Snapshot rápido
CLINTEC
ST13
US500000079100249Classe
Pedido
Registro
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Código do desenho
Tipo de titular
Localização do titular
Examinador
Unidade examinadora
Localização atual
Titulares
Representantes
Arlene D. Hanks Moore & Van Allen PLLC
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Business consultation in the field of clinical research [ and pharmaceutical commercialisation; ] compilation and systemization of information into computer databases; database management for others of a database comprised of data collected for clinical and biostatistics research purposes; personnel recruitment and placement in the field of clinical research; compilation and provision of statistical analysis reports; [ statistical consulting services for pharmaceutical, biotechnology and medical device industries for business purposes; ] creation and implementation of statistical analysis plans for business purposes; writing of business reports; business strategic planning [ ; market research, assessment, analysis and evaluation; business feasibility studies ]
Classe 41
[ Educational and ] training services in the field of clinical trials regulation and clinical research; [ Providing, arranging and conducting workshops, seminars, and educational conferences in the field of clinical trials regulation and clinical research; ] training in data capture and management; training [ and education ] in regulatory affairs; [ Providing, arranging and conducting training and educational classes, workshops, seminars, and education conferences in medical writing; providing, arranging and conducting training and educational classes, workshops, seminars, and education conferences training and education in quality control, auditing and inspection; writing of texts; ] training services, namely, training of clinical and scientific researchers to conduct clinical research and drug development studies
Classe 42
Scientific and technological services and research and design in the field of clinical trials and clinical research; industrial analysis and research services in the field of clinical trials and clinical research; clinical research services, namely, implementation of clinical studies and providing reports thereon; [ management of scientific research projects; conducting clinical research projects in the field of clinical trials and clinical research; ] conducting and monitoring clinical trials [ ; quality audit services, quality assurance consultancy, quality control testing in the field of quality control for others; technical inspection services, namely, inspection of clinical data, clinical procedure, clinical process, clinical database, and clinical reports for others; pharmaceutical product evaluation; design and conducting of technical feasibility studies; drug development services; quality management of drug development; preparation of reports in relation to clinical trials and clinical research, including preparation of reports on management of scientific research projects, clinical research projects, clinical trials, audits, pharmaceutical product evaluations, drug development and pharmaceutical product evaluations ]
Classe 45
[ Advisory and consultancy services relating to regulatory affairs in the field of clinical trials, clinical research and drug development; ] advisory and consultancy services relating to national and international regulation of clinical trials and drug development
Histórico de despachos e eventos da marca no USPTO.
55 publicações encontradas
PARTIAL INVALIDATION PROCESSED BY THE IB
17/03/2024
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
03/02/2024
INVALIDATION PROCESSED
02/02/2024
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
24/01/2024
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
24/05/2023
REGISTERED-SEC.71 ACCEPTED
24/05/2023
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
22/05/2023
POST REGISTRATION ACTION MAILED - SEC.71
22/12/2022
POST REGISTRATION ACTION CORRECTION
22/12/2022
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
22/12/2022
TEAS SECTION 71 RECEIVED
29/06/2022
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
26/06/2021
INTERNATIONAL REGISTRATION RENEWED
25/03/2021
NEW REPRESENTATIVE AT IB RECEIVED
22/01/2021
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
15/01/2019
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
15/01/2019
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
02/12/2017
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
02/12/2017
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/12/2017
TEAS SECTION 71 & 15 RECEIVED
03/11/2017
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
26/06/2017
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
28/09/2014
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
28/09/2014
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/08/2013
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/08/2013
NOTIFICATION PROCESSED BY IB
02/12/2012
FINAL DECISION TRANSACTION PROCESSED BY IB
15/10/2012
FINAL DISPOSITION NOTICE SENT TO IB
26/09/2012
FINAL DISPOSITION PROCESSED
26/09/2012
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
26/09/2012
REGISTERED-PRINCIPAL REGISTER
26/06/2012
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
17/05/2012
CORRECTION TRANSACTION RECEIVED FROM IB
11/05/2012
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/04/2012
PUBLISHED FOR OPPOSITION
10/04/2012
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/04/2012
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/04/2012
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
21/03/2012
LAW OFFICE PUBLICATION REVIEW COMPLETED
05/03/2012
ASSIGNED TO LIE
29/02/2012
APPROVED FOR PUB - PRINCIPAL REGISTER
11/02/2012
TEAS/EMAIL CORRESPONDENCE ENTERED
10/02/2012
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/02/2012
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/02/2012
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
18/10/2011
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
18/10/2011
REFUSAL PROCESSED BY IB
27/08/2011
APPLICATION FILING RECEIPT MAILED
11/08/2011
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/08/2011
REFUSAL PROCESSED BY MPU
10/08/2011
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/08/2011
NON-FINAL ACTION WRITTEN
09/08/2011
ASSIGNED TO EXAMINER
08/08/2011
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/08/2011
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/08/2011
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.